ArticleBiochemical pharmacology2013

3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.

Igor A Schepetkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.